New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...

Cancer Research UK, Cytovation, and the Norwegian Cancer Society have teamed up to advance the treatment of adrenocortical carcinoma (ACC). The collaboration will support the Phase II clinical trial ...

Learn about the gut-brain connection in mental health and how targeting serotonin in the gut could revolutionise ...

New study reveals that TLE6 protein deficiency causes male infertility in mice. These findings suggest potential genetic causes and future treatment avenues for male infertility. Genetic changes are a ...

Most popular... New genetic mechanism could lead to RNA therapies for mental health Advancing obesity drug discovery: Cell-based assays for GLP-1 and the G-Suite How GPCR agonists, including ...

UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage in type 1 diabetes. Researchers at the University of Virginia Center for Diabetes Technology have ...

Casdozokitug, combined with atezolizumab and bevacizumab, shows durable responses and a 17.2% complete response rate in HCC ...

Glox Therapeutics secures £500K from a £3M fund to develop antibiotics targeting antimicrobial-resistant lung infections in ...

Rigel Pharmaceuticals has enrolled the first patient in a Phase I trial to evaluate fostamatinib as a treatment for sickle ...

Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying early biomarkers for Parkinson’s disease (PD). Grifols has received funding ...